EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon Gamma Gene Polymorphisms in Greek Primary Breast Cancer Patients

Nyanbol Kuol, Xu Yan, Jimsheena Karakkat, Stamatis Vassilaros, Ioannis Fyssas, Anastasios Tsibanis, Sarah Fraser, Kulmira Nurgali, Vasso Apostolopoulos

Frontiers in Bioscience-Scholar · 2024

DOI: 10.31083/j.fbs1604025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Scholar, 2024. Verfasst von Nyanbol Kuol und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Interferon-gamma, Polymorphism, Single Nucleotide. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Thelma and Paul Constantinou Foundation, Graeme & Angelina Wise, AHEPA Victoria Unit Athena 2 Daughters of Penelope.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is a heterogeneous disease with distinct clinical subtypes, categorized by hormone receptor status, which exhibits different prognoses and requires personalized treatment approaches. These subtypes included luminal A and luminal B, which have different prognoses. Breast cancer development and progression involve many factors, including interferon-gamma (IFNG). Moreover, single nucleotide polymorphisms (SNPs) in IFNG have been associated with cancer risk. However, the functional role of IFNG polymorphisms in primary breast cancer subtypes, luminal A and luminal B, is unclear.

Methods

A total of 138 breast cancer tissues were acquired: 81 had luminal A, 42 had luminal B, 10 had triple-negative, and 3 had human epidermal growth factor receptor 2 (HER2) subtypes, while 2 had missing data. The tissues were evaluated in relation to luminal A and luminal B primary breast cancer subtypes. DNA was extracted from freshly frozen samples, and three SNPs (rs1861493 (chr12:68157416 (GRCh38.p13)), rs1861494 (chr12:68157629 (GRCh38.p13)) and rs2430561 (chr12:68158742 (GRCh38.p13))) in the IFNG gene were selected and evaluated based on previously published associations with cancer or other diseases.

Results

The data showed that IFNG polymorphisms rs1861493 and rs1861494 were associated with breast cancer risk, with the A allele of rs1861493 and T allele of rs1861494 being noted as the risk alleles. Furthermore, the IFNG polymorphism rs2430561 was associated with breast cancer risk, with the A allele being the risk allele. In addition, the risk alleles were more prevalent in the more aggressive subtype, luminal B breast cancer, compared to luminal A. Similarly, the rs2430561 AA genotype was associated with the breast cancer severity.

Conclusion

IFNG polymorphisms rs1861493, rs1861494, and rs2430561, with their respective risk alleles, are associated with increased breast cancer risk and severity. These risk alleles are more prevalent in the aggressive luminal B subtype compared to luminal A, indicating their role in both the prevalence and prognosis of breast cancer in a Greek population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsInterferon-gammaPolymorphism, Single NucleotideHumansFemaleGreeceMiddle AgedAgedAdultGenetic Predisposition to Disease

Stichwörter der Autor:innen

SNPsbreast cancerinterferon-gammaluminal Aluminal Bsingle nucleotide polymorphismssubtypes

Substanzen

Interferon-gammaIFNG protein, human

Autor:innen und Institutionen

  • Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
  • Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA.
  • Prolipsis Diagnostic Centre - Clinic, 11528 Athens, Greece.
  • Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC 3021, Australia.
  • Department of Medicine Western Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3021, Australia.
  • School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia.

Förderung

  • The Thelma and Paul Constantinou Foundation
  • Graeme & Angelina Wise
  • AHEPA Victoria Unit Athena 2 Daughters of Penelope
  • Australian Postgraduate Research Award

Zitieren

APA

Kuol, N., Yan, X., Karakkat, J., Vassilaros, S., Fyssas, I., Tsibanis, A., Fraser, S., Nurgali, K., & Apostolopoulos, V. (2024). Interferon Gamma Gene Polymorphisms in Greek Primary Breast Cancer Patients. Frontiers in Bioscience-Scholar. https://doi.org/10.31083/j.fbs1604025

Vancouver

Kuol N, Yan X, Karakkat J, Vassilaros S, Fyssas I, Tsibanis A, et al. Interferon Gamma Gene Polymorphisms in Greek Primary Breast Cancer Patients. Frontiers in Bioscience-Scholar. 2024. doi:10.31083/j.fbs1604025

BibTeX
@article{Kuol2024,
  author = {Kuol, Nyanbol and Yan, Xu and Karakkat, Jimsheena and Vassilaros, Stamatis and Fyssas, Ioannis and Tsibanis, Anastasios and Fraser, Sarah and Nurgali, Kulmira and Apostolopoulos, Vasso},
  title = {Interferon Gamma Gene Polymorphisms in Greek Primary Breast Cancer Patients},
  journal = {Frontiers in Bioscience-Scholar},
  year = {2024},
  doi = {10.31083/j.fbs1604025}
}
Kostenlos starten →